Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on June 26, 2006

Hypertension. 2006
Published online before print June 26, 2006, doi: 10.1161/01.HYP.0000231934.67549.b7
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/2/323    most recent
01.HYP.0000231934.67549.b7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qi, Z.
Right arrow Articles by Breyer, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qi, Z.
Right arrow Articles by Breyer, M. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Lipids

Submitted on March 16, 2006
Revised on April 5, 2006

Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta

Zhonghua Qi*; Hui Cai; Jason D. Morrow; and Matthew D. Breyer

From the Division of Nephrology (Z.Q., M.D.B.), Department of Medicine, and the Departments of Internal Medicine (H.C.), Pharmacology (J.D.M.), and Molecular Physiology and Biophysics (M.D.B.), Vanderbilt University, Nashville, Tenn; and the Veterans Administration Medical Center (M.D.B.), Nashville, Tenn.

* To whom correspondence should be addressed. E-mail: zhonghua.qi{at}vanderbilt.edu.

Abstract--Accumulating evidence indicates cyclooxygenase (COX) 1 and COX2 differentially regulate cardiovascular and renal function. We have demonstrated previously in mice that COX2 inhibition enhances angiotensin II-induced hypertension, and COX1 inhibition attenuates the pressor effect of angiotensin II. To further elucidate the mechanism underlying the functional difference of COX1 versus COX2 inhibition, the present studies examined the prostaglandin (PG) profiles derived in COX1- or COX2-inhibited mouse kidney and aorta using gas chromatographic/mass spectrometric assays. PGE2 is the most abundant prostanoid in both renal cortex and medulla in normal C57BL/6J mice, followed by PGI2, PGF2{alpha} and thromboxane A2. In contrast PGI2 was most abundant in aorta followed by thromboxane A2, PGE2, and PGF2{alpha}. PGD2 was undetectable in control kidney or aorta. At baseline, inhibition of COX1 decreased total prostaglandins in renal cortex, medulla, and aorta, whereas COX2 inhibition decreased total prostaglandins only in renal medulla. Angiotensin II infusion significantly increased COX2-dependent/COX1-independent PGE2 and PGI2 in renal cortex and medulla. Angiotensin II also significantly increased renal PGF2{alpha} in cortex, but not in medulla, through both COX1- and COX2-dependent mechanisms. These studies demonstrate that although COX1 primarily contributes to basal prostanoid production in the kidney and aorta, angiotensin II increases renal vasodilator prostanoids predominately via COX2 activity. These effects may contribute to the specific effect of COX2 inhibitors to increase blood pressure.


Key words: prostaglandins • cyclooxygenase • angiotensin II • kidney • mice




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Araujo and W. J. Welch
Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F790 - F794.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
J. Azzarello, K.-M. Fung, and H.-K. Lin
Tissue Distribution of Human AKR1C3 and Rat Homolog in the Adult Genitourinary System
J. Histochem. Cytochem., September 1, 2008; 56(9): 853 - 861.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. A. Jaimes, M.-S. Zhou, D. D. Pearse, L. Puzis, and L. Raij
Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F385 - F392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. R. Ansari, A. Nadeem, S. L. Tilley, and S. J. Mustafa
Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3448 - H3455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M.-E. Gendron and E. Thorin
A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2508 - H2515.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst
Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Alvarez, J. V. Perez-Giron, R. Hernanz, A. M. Briones, A. Garcia-Redondo, A. Beltran, M. J. Alonso, and M. Salaices
Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 381 - 388.
[Abstract] [Full Text] [PDF]